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AbsTrACT
Objective the crypt population in the human intestine 
is dynamic: crypts can divide to produce two new 
daughter crypts through a process termed crypt fission, 
but whether this is balanced by a second process to 
remove crypts, as recently shown in mouse models, 
is uncertain. We examined whether crypt fusion (the 
process of two neighbouring crypts fusing into a single 
daughter crypt) occurs in the human colon.
Design We used somatic alterations in the gene 
cytochrome c oxidase (ccO) as lineage tracing markers 
to assess the clonality of bifurcating colon crypts (n=309 
bifurcating crypts from 13 patients). Mathematical 
modelling was used to determine whether the existence 
of crypt fusion can explain the experimental data, and 
how the process of fusion influences the rate of crypt 
fission.
results in 55% (21/38) of bifurcating crypts in which 
clonality could be assessed, we observed perfect 
segregation of clonal lineages to the respective crypt 
arms. Mathematical modelling showed that this 
frequency of perfect segregation could not be explained 
by fission alone (p<10−20). With the rates of fission and 
fusion taken to be approximately equal, we then used 
the distribution of ccO-deficient patch size to estimate 
the rate of crypt fission, finding a value of around 0.011 
divisions/crypt/year.
Conclusions We have provided the evidence that 
human colonic crypts undergo fusion, a potential 
homeostatic process to regulate total crypt number. the 
existence of crypt fusion in the human colon adds a new 
facet to our understanding of the highly dynamic and 
plastic phenotype of the colonic epithelium.
InTrODuCTIOn
The epithelial lining of the intestine is a highly 
dynamic population of rapidly renewing cells. The 
cells are organised into millions of small invagina-
tions called crypts, and the base of each crypt houses 
a small population (<10) of actively dividing stem 
cells,1 the progeny of which migrate proximally 
along the crypt axis, become differentiated and 
are subsequently shed into the bowel lumen.2 3 In 
mice, the majority of cells within the small intestinal 
crypt are renewed every few days,4 while renewal of 
the human colon epithelium is measured to occur 
in slightly less than a week.5 Competition between 
cells for space in the stem cell niche located at the 
crypt base maintains homeostasis of cell number.6–8 
The population of crypts is also dynamic. Crypt 
fission, the bifurcation of a parental crypt into two 
daughters, is responsible for postnatal expansion 
significance of this study
What is already known on this subject?
 ► Expansion of somatic mutations within the 
human colonic epithelium occurs through crypt 
fission, the process by which a parental crypt 
divides and produces two daughter crypts. 
Fission occurs at a low rate in the healthy adult 
colon; however, it is more frequent in certain 
disease states.
 ► As crypt density and colon length do not appear 
to increase over time, total crypt number must 
be regulated by a homeostatic process in which 
the fission-driven increase in crypt number is 
balanced by a process that decreases crypt 
number.
 ► A recent study has shown that, in the mouse 
intestine, two parental crypts can fuse into one 
daughter crypt in a process termed crypt fusion.
What are the new findings?
 ► Clonal lineage tracing analysis provides 
evidence for crypt fusion in the human colon, 
and suggests the rate of crypt fusion is 
balanced with that of crypt fission.
 ► Mathematical modelling that accounts for crypt 
fusion indicates that crypt fission occurs 20% 
more frequently (rate 0.011 divisions/crypt/
year) than a previous estimation.
How might it impact on clinical practice in the 
foreseeable future?
 ► Crypt fusion may be a homeostatic mechanism 
to maintain intestinal epithelium integrity. 
Understanding the drivers of fusion could 
lead to new epithelial regeneration inducing 
therapies.
 ► Crypt fission is responsible for the spread of 
mutations in the early stages of colorectal 
tumourigenesis, and also for the regeneration 
of the colonic epithelium after injury. 
Consequently, manipulating the balance 
of crypt fission and fusion may represent a 
novel strategy for the prevention of the early 
expansion of precancerous mutant clones 
within the colonic epithelium.
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in crypt number9 and is observed to occur at a low rate in the 
healthy adult colon in both human and mouse.3 10–12 However, 
despite this low level fission—a growth process—there does not 
appear to be an increase in the total number of crypts in the 
intestine during ageing (the density of crypts and length of intes-
tine do not appear to increase with age in mice13 or humans14) 
suggesting that the rate of crypt fission must be matched by an 
equal rate of crypt death. If, for example, every crypt in the colon 
divided only once in an adult lifetime, then the crypt number 
would double. Given that there is no direct histological evidence 
of crypt death in healthy colon (although it is clear that crypts 
can die and regrow in pathological conditions, such as in IBD15), 
it suggests that either crypt death is an extremely rapid process, 
or that some other hitherto unidentified homeostatic mecha-
nism maintains crypt number. Recent measurements in mice 
have provided evidence for the latter: a combination of multico-
lour genetic labelling and intravital imaging showed the merging 
of two intestinal crypts (labelled with different colours) into a 
single new crypt over the course of a few days, a process that 
the authors termed crypt fusion.13 Furthermore, they showed 
that at a given timepoint postlabelling, 3.5% of labelled crypts 
were in fission and 4.1% were in fusion, suggesting that the two 
processes occur at approximately similar frequency.
Whether or not crypt fusion occurs in the human colon 
remains undetermined, as the transgenic labelling and live-im-
aging approach applied successfully in mice cannot be trans-
lated to humans. Instead, an approach that can be readily 
applied to human tissue is to exploit naturally occurring somatic 
mutations as lineage tracing markers, and examine the spatial 
distribution of mutant clones in tissue from older patients. 
Using this approach, we and others have shown that the distri-
bution of crypt patch size—the number of adjacent crypts all 
bearing the same somatic mutation—increases with age in the 
colon3 10 11 providing evidence of ongoing crypt fission during 
ageing. Attempts to infer crypt death (or fusion) rates directly 
from these data requires longitudinal measurement; thus, an 
alternative approach is needed.
Here, we provide evidence of crypt fusion in the human 
colon. We have used naturally occurring somatic mutations 
that cause a histochemically detectable defect as clonal lineage 
tracing markers, and specifically analyse the clonal composition 
of branched crypts, which could be the intermediate products 
of either fission or fusion. We hypothesised that only crypts in 
fusion, and not those in fission, would be likely to show ‘perfect 
segregation’ of labelled and unlabelled lineages into the respec-
tive arms of the bifurcating crypt. We used mathematical model-
ling to assess the validity of this hypothesis given the data and 
show that only by allowing for fusion can we explain our obser-
vations. Finally, we revise the estimation of crypt fission rate 
in the human colon in the light of this new evidence for crypt 
fusion.
resulTs
evidence for crypt fusion in human colon
We examined the spatial segregation of distinctly labelled clones 
within bifurcating crypts in human colon. Fresh frozen colonic 
mucosa was obtained from 13 patients (aged 39–79 years, 
Table 1 Patient details and raw bifurcation counts
Patient
ref Disease Age
Total 
crypts CCO+ crypts
CCO−  
crypts
CCO 
partial 
crypts
Total 
bifurcation 
events
Type I 
bifurcation 
events
(% of total)
Type II 
bifurcation 
events
(% of total)
Type III 
bifurcation 
events
(% of total)
Fission/fusion rate (per 
crypt per year)
(95% CI)
Duration of fission/
fusion (weeks)
(95% CI)
1 None 79 4919 4086 497 336 7 5 (71.4%) 2 (28.6%) 0 0.009 (0.007 to 0.011) 3.9 (3.1 to 4.7)
2 None 60 3547 3424 70 53 3 3 (100%) 0 0 0.005 (0.001 to 0.009) 4.1 (1.3 to 6.8)
3 None 64 6958 6798 101 59 5 5 (100%) 0 0 0.002 (0.001 to 0.003) 9.1 (2.5 to 15.7)
4 FAP 67 6417 5910 287 220 44 41 (93.2%) 1 (2.3%) 2 (4.5%) 0.017 (0.013 to 0.021) 10.7 (8.1 to 13.2)
5 FAP 59 4095 3713 193 189 23 20 (87.0%) 3 (13.0%) 0 0.033 (0.024 to 0.042) 4.4 (3.2 to 5.7)
6 FAP 39 3085 3018 43 24 48 48 (100%) 0 0 0.010 (0.002 to 0.019) 40.7 (6.8 to 74.6)
7a AFAP 64 5448 5213 148 87 54 50 (92.6%) 3 (5.6%) 1 (1.9%) 0.012 (0.008 to 0.017) 20.9 (13.3 to 28.6)
7b AFAP 64 5065 4463 291 311 25 20 (80.0%) 3 (12.0%) 2 (8.0%) 0.012 (0.008 to 0.015) 11.0 (8.0 to 14.0)
8 AFAP 65 11 755 11 351 213 191 25 18 (72.0%) 0 7 (28.0%) 0.014 (0.010 to 0.018) 3.9 (2.8 to 5.1)
9 AFAP 61 4174 3641 282 251 27 20 (74.1%) 2 (7.4%) 5 (18.5%) 0.027 (0.021 to 0.034) 6.2 (4.7 to 7.7)
10 AFAP 60 2038 1962 52 24 16 14 (87.5%) 1 (6.3%) 1 (6.3%) 0.011 (0.004 to 0.019) 17.1 (6.3 to 28.0)
11a IBD 66 272 256 15 1 3 3 (100%) 0 0 ND ND
11b IBD 66 402 378 21 3 1 1 (100%) 0 0 ND ND
12 IBD 72 301 238 58 5 3 1 (33.3%) 0 2 (66.7%) ND ND
13 IBD 65 1245 1057 102 86 25 22 (88.0%) 2 (8.0%) 1 (4.0%) ND ND
14 None 42 2702 ND ND ND ND ND ND ND 0.020 (0.006 to 0.034) ND
15 None 50 2878 ND ND ND ND ND ND ND 0.009 (0.001 to 0.017) ND
16 None 50 2883 ND ND ND ND ND ND ND 0.015 (0.006 to 0.024) ND
17 None 62 12 030 ND ND ND ND ND ND ND 0.007 (0.004 to 0.010) ND
18 None 65 29 839 ND ND ND ND ND ND ND 0.003 (0.002 to 0.004) ND
19 None 72 4101 ND ND ND ND ND ND ND 0.005 (0.002 to 0.008) ND
20 None 74 8792 ND ND ND ND ND ND ND 0.014 (0.011 to 0.017) ND
21 None 74 22 045 ND ND ND ND ND ND ND 0.012 (0.010 to 0.014) ND
22 None 80 6249 ND ND ND ND ND ND ND 0.014 (0.010 to 0.018) ND
23 None 82 10 341 ND ND ND ND ND ND ND 0.016 (0.014 to 0.018) ND
24 None 84 11 821 ND ND ND ND ND ND ND 0.024 (0.020 to 0.028) ND
Patients 1–13 had serial sections available and were used to score crypt bifurcation frequencies. 
Patients 14–24 had only a single section available and were used to assess CCO− patch size.
AFAP, attenuated familial adenomatous polyposis; CCO, cytochrome c oxidase; FAP, familial adenomatous polyposis; ND, not detemined.
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patients 1–13 in table 1), including 7 people with familial adeno-
matous polyposis (FAP) or attenuated FAP (AFAP) who carry a 
germline pathogenic APC mutation, and 3 people with IBD. Both 
disease conditions are known to exhibit an increased rate of crypt 
bifurcation compared with healthy colon.15 16 Tissue was orien-
tated such that the crypt axes were perpendicular to the section 
plane (en face) and sectioned serially from the luminal end of the 
crypt to the crypt base. Manual inspection of the serial sections 
led to the identification of a total of 309 ‘bifurcation events’ 
(59 721 crypts inspected, 0.52% bifurcating; table 1), where two 
crypts shared a region of epithelium. We observed an increased 
rate of bifurcation in diseased colon (normal colon=0.09%, 
AFAP/FAP colon=0.62%, IBD colon=1.44%, p=0.009 by the 
Kruskal-Wallis test) in agreement with previous reports,15 16 
although with somewhat lower estimations of the proportion 
of bifurcating crypts. Previously, such bifurcation events were 
classified as a single crypt in the process of fission. However, 
based on static histological measures alone, these events could 
equally be associated with the fusion of neighbouring crypts. To 
discriminate between these possibilities, we considered whether 
temporal information could be inferred from clonal data.
To identify clonal lineages, we stained each specimen for 
cytochrome c oxidase (CCO) activity. Spontaneous loss of CCO 
activity (CCO−) is observed in the ageing human colon,17 and 
by age 80 approximately 30% of crypts show CCO deficiency11 
that is readily visualised by enzyme histochemistry.3 11 17 CCO is 
a mitochondrially encoded gene, and CCO− is typically attrib-
utable to an underlying somatic mitochondrial DNA mutation.17 
Single cell sequencing of the mitochondrial genome demon-
strates the clonality of an expanded CCO− patch.17 Thus, loss 
of CCO activity provides a naturally occurring, easily visualised, 
clonal mark in human tissues.
The majority of bifurcating crypts (251/309; 81.2%) were 
entirely CCO-proficient (CCO+, ‘type I’, figure 1 and table 1); 
these were considered uninformative as they could be the inter-
mediate product of either fission or fusion. Rare bifurcation 
events that involved partial CCO-deficient crypts (20/309, 
6.5%) were also classed as ‘type I’ events. There were 17/309 
(5.5%) of bifurcations that were entirely CCO-deficient 
(CCO−, ‘type II’, figure 1 and table 1), and we hypothesised 
that, due to the low frequency of CCO deficiency, these are 
highly likely to be the product of fission. The remaining 21/309 
(6.8%) of bifurcations contained a mixture of CCO− and 
CCO+ cells, with the CCO+ and CCO− lineages, respectively 
restricted to single bifurcating crypt arms (‘type III’, figure 1, 
table 1 and online supplementary figure 1). We hypothesised 
that these ‘perfectly segregated bifurcating crypts’ are inter-
mediates of the fusion of neighbouring CCO− (labelled) and 
CCO+ (unlabelled) crypts. Thus, out of a total of 38 bifur-
cating crypts where clonality could be accurately assessed, 
21/38 (55%) were suggestive of fusion, and 17/38 (45%) were 
suggestive of fission.
We generated a three-dimensional (3D) reconstruction of a 
‘type III’ bifurcation (online supplementary figure 2, supplemen-
tary videos 1 and 2) using digitised serial images of thin tissue 
sections. This detailed histological analysis shows that the bifur-
cating crypts analysed stayed closely associated through approx-
imately half of the length of the crypt, forming one lumen close 
to the proximal surface. In the lower half of the crypts, the two 
bifurcated arms were clearly separated by stroma. The cellular 
contributions from each arm (respectively blue CCO− and 
brown CCO+ cells) show no intermixing in the shared prox-
imal region. The lack of intermixing CCO− and CCO+ lineages 
at the proximal end of the merged crypt was also evident in a 
second crypt that we studied in detail (online supplementary 
video 3).
We took a frequentist hypothesis testing approach to eval-
uate the null hypothesis that these data could be explained by 
fission alone. We note that crypt death is not expected to cause 
crypt bifurcation, and so is irrelevant to the following mathe-
matical argument. Specifically, we calculated the likelihood that 
a mixed CCO−/CCO+ parent crypt undergoing fission would, 
by chance, perfectly segregate the CCO− and CCO+ lineages 
into separate arms as it bifurcated. Our calculation assumed that 
a crypt contained a small number of stem cells (S) that were in 
neutral competition3 6–8 10 and that the rate at which new CCO− 
lineages developed was very small. On the initiation of fission, 
we assumed that stem cells were segregated in equal numbers to 
the two daughter crypts (S/2 stem cells into each daughter crypt), 
and so for perfect segregation of CCO− and CCO+ lineages to 
occur, exactly S/2 stem cells had to be CCO− at the moment 
that fission was initiated. Thus, we estimated the probability that 
a crypt would contain S/2 labelled stem cells on the initiation of 
fission, and used this value to calculate the chance of observing 
the 21 type III crypts among 309 bifurcating crypts (see online 
supplementary mathematical note). For the plausible range 
of S values (S=[5−10]), the probability of observing 21/309 
perfectly segregated bifurcating crypts by fission alone was negli-
gible (p<10−20 for all values of S; see online supplementary table 
1). Hence, we rejected the null hypothesis and assumed a role for 
crypt fusion in explaining our data.
balanced rates of crypt fission and fusion
To determine if the rates of crypt fission and fusion are balanced 
in the human colon, we compared the number of ‘type II’ bifur-
cation events (likely fission) to the number of ‘type III’ bifur-
cation events (likely fusion). Assuming that the probability of 
observing a type II or type III event is proportional to the rate 
of fission or fusion, respectively, and that the amount of time a 
crypt undergoing fission or fusion spends in a bifurcating state 
is approximately equal, then if the fission and fusion rate were 
equal we would expect the number of type II or type III events 
to be similar. We find that the frequency of these events is similar 
(45% vs 55% of labelled bifurcations, respectively; table 1), 
supporting the idea of balanced rates of fission and fusion in the 
human colon.
revision of the crypt fission rate
We next sought to estimate the rate of crypt fission and fusion 
in the human colon, defined as the number of fission or fusion 
events an individual crypt undergoes per year. For this analysis, 
we used only the distribution of CCO− crypt ‘patch size’—where 
a patch was defined by the number of adjacent CCO− crypts 
(figure 2A). Therefore, we were able to analyse a larger cohort 
of 21 patients, in each of which we measured CCO− patch size 
in an area representing at least 2000 total crypts (14 disease-free 
patients and 7 AFAP/FAP patients, figure 2B and C, patients 1–10 
and 14–24 in table 1, data largely from Baker et al3). Previous 
estimates of the crypt fission rate derived from this type of data 
have not considered the impact of crypt fusion.3 10 We reasoned 
that fission of a CCO− crypt would increase the patch size by 1, 
whereas fusion would decrease the patch size by 1 if two CCO− 
crypts fused, or decrease the patch size by 1 with 50% proba-
bility if a CCO− and a neighbouring CCO+ crypt fused. We 
used a birth-death process to model CCO− patch size evolution 
(see online supplementary mathematical note).
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Figure 1 Analysis of cytochrome c oxidase (CCO) activity in bifurcating crypts. (A) Schematic diagram showing the distribution of CCO activity in 
type I, II and III bifurcation events. (B) Representative images of type I, II and III bifurcating crypts, with the upper row corresponding to the most 
luminal section and the lower row corresponding to the crypt base. The type I and III examples are taken from patient 8 and the type II example is 
from patient 4. Scale bars represent 50 μm.
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Mathematically, the fission and fusion rates are not separately 
identifiable from the patch size distribution alone (see online 
supplementary mathematical note). Consequently, given that 
we found evidence in support of balanced rates of fusion and 
fission, we set their respective rates to be equal. For simplicity, 
we considered fusion and fission events to be spatially and 
temporarily uncorrelated so that the average crypt number is 
constant, while the local density may fluctuate (see below for 
an assessment of this assumption). Then, based on the predicted 
distribution of patch sizes, a maximum likelihood estimate of the 
fission rate was made for each sample (table 1, figure 2D, online 
supplementary figure 3), with a mean fission rate in the disease-
free colon of 0.011 divisions/crypt/year (range 0.002–0.024), 
corresponding to a mean crypt cycle length of approximately 90 
years. This estimate is approximately 20% higher than if only 
fission were simulated (mean fission rate=0.009 divisions/crypt/
year [range 0.002–0.018], crypt cycle=110 years). A previous 
investigation of the fission rate that did not consider the poten-
tial for crypt fusion and was based on histological analysis of 
an alternative neutral marker was 0.0068 divisions/crypt/year, 
translating to a crypt cycle of approximately 150 years.10 One 
potential explanation for the small difference between these two 
rate estimates is divergence in the age-related accumulation of 
the differing clonal marks used in the respective studies, due to 
unmeasured fluctuations in the mutation rate (labelling rate) or 
non-neutral evolutionary dynamics of the mutant clones.
Similarly, the crypt fission rate in the AFAP/FAP colon was 
inferred from CCO patch size distributions. The mean fission 
rate of these patients was 0.017 divisions/crypt/year (range 
0.0099–0.032, table 1, figure 2D), corresponding to a crypt 
cycle length of 60 years. This was not significantly different to 
that of the disease-free colon (p=0.11 by the two-sided Mann-
Whitney U test), but we acknowledge that the sample size of our 
study means that it was not powered to detect smaller differ-
ences in fission/fusion rates.
estimation of the duration of fission/fusion
In mouse, the duration of crypt fission is approximately 1 week.13 
The duration of fission in human samples is unknown as longitu-
dinal measurements are not feasible. We used the per-patient esti-
mate of the crypt fission rate and the number of bifurcating crypts 
in a single section to estimate the time taken to complete fission. 
We assumed that approximately half of observed bifurcations were 
the result of fission. Thus, the duration of crypt fission was mathe-
matically estimated as the fraction of crypts undergoing fission at 
a given time divided by the fission rate. The median fission dura-
tion for the 10 informative patients (3 disease-free and 7 AFAP/
FAP, patients 1–10 in table 1) was calculated to be 9 weeks (range 
4–41 weeks, table 1). There was no statistically significant differ-
ence between fission duration in the healthy colon and the AFAP/
FAP colon (p=0.18 by the two-sided Mann-Whitney U test).
Figure 2 Analysis of cytochrome c oxidase (CCO) patch size distribution. (A) Representative example of a CCO-deficient patch of three crypts in 
the colonic epithelium. Scale bar represents 100 μm. (B) Distribution of total CCO-deficient patches, and number of patches of size n for each patient. 
(C) Relationship between patient age and mean CCO-deficient patch size. Shown is the age and mean CCO-deficient patch size of each individual 
patient (blue dots represent the disease-free ‘normal’ colon, and red dots represent the attenuated familial adenomatous polyposis [AFAP]/familial 
adenomatous polyposis [FAP] colon). The black line represents the predicted mean patch size over time for a hypothetical patient with a fission and 
fusion rate equal to the mean fission and fusion rate of the patient cohort. (D) Estimated fission/fusion rate for each patient, arranged first by disease 
status, then by ascending age. Error bars represent 95% CIs.
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spatial correlation of fission and fusion events
Local variations in the microenvironment could conceivably 
drive crypt fission/fusion events. To examine this hypoth-
esis, we examined whether bifurcation events were spatially 
correlated. We selected samples consisting of at least 2000 crypts 
(three disease-free patients and seven AFAP/FAP patients), and 
computed the Ripley’s L spatial clustering statistic on the loca-
tions of bifurcating crypts. We found that six samples (samples 
4, 6, 7a, 7b, 8 and 10) showed statistically significant spatial 
correlation of bifurcation events (p<0.01; Monte Carlo test; 
online supplementary figure 4 and online supplementary math-
ematical note). The low numbers of type II and type III crypts 
precluded formal assessment of clustering of putative fission and 
fusion events.
We note that if fission/fusion acts to maintain homeostasis 
of local crypt density by respectively increasing/decreasing 
local crypt number, then a reasonable hypothesis is that when 
averaged over long times fission/fusion rates are fairly uniform 
across the colon. Indeed, the good fit of our model with uniform 
fission/fusion rates, and lack of multimodality in the patch size 
data (online supplementary figure 3) is supportive of this idea.
Methylation analysis in a bifurcating crypt provides support 
for fusion
Finally, we sought to provide evidence of crypt fusion using 
an orthogonal methodology. DNA methylation at CpG sites 
in unexpressed genes is subject to neutral drift, and so closely 
related crypts are expected to have more similar methylation 
tags than unrelated crypts.18 We and others have previously used 
bisulfite sequencing to analyse the methylation patterns of both 
arms of branching crypts (presumed fission intermediates) and 
unexpectedly found them to be as distinct as unrelated crypts.18 19 
We hypothesised that an explanation of this observation is that 
branched crypts could be intermediates of fusion rather than 
fission. In a single bifurcating crypt isolated from a patient with 
IBD, we performed bisulfite sequencing of the cardiac-specific 
homeobox (CSX) gene (unexpressed in the human colon) in the 
two arms and the stalk of the bifurcating crypt (figure 3). We 
found that the two arms did not share any methylation tags, 
suggesting they are not closely related. Furthermore, we found 
that the stalk contained a mixture of tags found in both arms. 
This ‘perfect segregation’ of methylation tags in the two arms of 
the bifurcating crypt is suggestive of a fusion event.
DIsCussIOn
Here, we provide evidence that the merging of adjacent colon 
crypts—the process of crypt fusion—occurs in the human colon. 
Our analysis is suggestive that, in healthy bowel, the rate of 
crypt fusion matches the rate of crypt fission, suggesting that 
fission/fusion events are homeostatic mechanisms that together 
maintain the population size of crypts in the colon. While our 
analysis does not rule out the potential further mechanisms of 
Figure 3 Analysis of cardiac-specific homeobox (CSX) methylation in a bifurcating crypt. Image of a bifurcating crypt, with the two buds (‘A’ and ‘B’) 
and the crypt stalk ‘S’ isolated and used for analysis of CSX methylation status. Each row represents the CSX methylation tag of an individual clone. 
Open circles represent an unmethylated CpG site and closed circles represent a methylated CpG site. The two buds share no methylation tags, and the 
stalk contains tags from both ‘A’ and ‘B’.
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crypt death (such as ‘crypt apoptosis’), the evidence provided 
herein, that fission/fusion occur at approximately equal rates 
does suggest that alternative mechanisms of crypt loss, such as 
death, are likely to be rare events. In general, that crypts are 
capable of fusing further highlights the plasticity of the epithe-
lial cell population in the colon. We and others have thought of 
crypts/glands as the basic ‘units of selection’ throughout the GI 
tract20—in other words that crypts can be considered as automa-
tous homogeneous units to explain patterns of intercrypt clonal 
expansion in the colon. That crypts can fuse—and so merge their 
identity—requires nuancing of this simplistic view.
The cellular-molecular mechanisms that regulate crypt fission 
and fusion remain to be elucidated. Potentially, fusion could be 
induced to ‘relieve’ local mechanocellular stresses induced by a 
prior fission of a nearby crypt. Indeed, we observe spatial clus-
tering of bifurcation events (online supplementary figure 4). 
Of much interest is the dynamics of niche-producing stromal 
cells21 22 from each crypt—prior to a fusion event there are two 
‘sets’ of these cells that reduce to a single set. Understanding how 
this is achieved may yield further mechanistic insight into the 
maintenance of homeostasis in the gut. Resolution of the induced 
stresses and strains in the basement membrane during the merger 
is also of interest. Similarly, determination of how epithelial 
cell fate is regulated during the merger process—particularly at 
the ‘saddle point’ between the two merging crypts—could be 
important for furthering our understanding of epithelial cell 
regulation in the crypt. Furthermore, if and how the dynamics of 
fission/fusion change during ageing and along the length of the 
colon may hold clues to the development and maintenance of 
the rapid-renewing intestinal epithelium throughout life.
The evolutionary pressure for crypt fission/fusion turnover 
is unclear. It is conceivable that fusion could be a compet-
itive process, whereby less ‘fit’ crypts are replaced by a fitter 
neighbour: in this regard, fusion could be way to heal ‘sick 
crypts’ (presumably less fit) without compromising epithelial 
barrier integrity. A fanciful idea is that crypt fusion could be 
tumour-suppressive via engulfment, and subsequent removal, of 
a ‘cancerised’ crypt23 by a healthy neighbour. On the other hand, 
such a mechanism could be subverted and drive the expansion 
of the mutant clone. Of course, some of kind of sensing between 
crypts—either direct or indirect—needs to be present for this 
type of crypt-competitive mechanism to be plausible. Certainly, 
as has been previously noted, fusion of a ‘cancerised’ crypt with 
a wild-type crypt would restart stem cell competition of a previ-
ously ‘fixed’ lineage, and so could lead to removal of tumouri-
genic mutations via a passive means.13 That fusion is simply a 
chance process, driven by stochastic events in the positioning 
of crypts and the epithelial cells within, the position and status 
of supporting microenvironmental cells, and/or the integrity of 
the basement membrane, also cannot be ruled out. Furthermore, 
we recognise the possibility that due to intrinsic or microenvi-
ronmental factors, fission or fusion events may not necessarily 
always reach completion, but may stall or even reverse. Although 
it is not possible to observe such ‘stalled’ events using our anal-
ysis, this eventuality could be more readily examined in mouse 
models where longitudinal observation is possible. If fission/
fusion can reverse it would imply that the crypt life cycle is a 
highly fluid and adaptable, and further reject the notion of the 
crypt as a ‘clonal unit’.
Mutations that occur within the stem cells of a crypt can spread 
throughout the crypt via a process of neutral competition. Recent 
estimates of the clonal fixation time within a crypt by Nicholson 
et al10 (median 6.3 years) are significantly longer than previous 
estimates from human data3 and experimental data from mouse 
models.6 7 Crypt fusion provides a mechanism, whereby crypt 
‘polyclonality’ can be reintroduced into a crypt, via the merging 
of two differentially labelled crypts. Accordingly, fusion would 
inflate the number of partially fixed crypts (compared with the 
case without crypt fusion), possibly leading to an underestimate 
of the effective replacement rate, or equivalently, an overesti-
mate of the fixation time. Accurate measurement of the distri-
bution of clone sizes within partially labelled crypts is a route to 
decouple neutral drift dynamics from the effects of fusion, but 
such data have not yet currently been generated.
Our mathematical analysis relies on a number of assump-
tions, foremost that stem cell numbers per crypt are small and 
constant, and that crypt fission causes equal segregation of stem 
cells between the two arms of the bifurcating crypt. We also 
assume that CCO deficiency is a neutral mark, that is induced at 
a constant rate throughout life. Although we consider that these 
assumptions are reasonable, we note that relaxing them weakens 
the strength of our evidence for crypt fusion. Nonetheless, we 
maintain that crypt fusion provides a parsimonious explanation 
of the high number of ‘type III’ bifurcation events that we have 
observed. In our estimation of the rate of crypt fusion, we note 
that we have neglected to consider other mechanisms of ‘crypt 
extinction’, and inclusion would alter our estimate of the crypt 
fission/fusion rate. The strength of our conclusions are natu-
rally limited by the available sample size, and the corresponding 
accuracy of the inferred fission/fusion rates are reflected by the 
reported broad CIs.
In summary, we present evidence of crypt fusion as a homeo-
static process in the human colon, nuancing our view of growth 
regulation in this rapidly renewing epithelium.
MeTHODs
CCO staining
Two-colour enzyme histochemistry for CCO activity was 
performed on serial sections at 12 µm thickness as previously 
described.11
Analysis of CCO activity, bifurcation events and CCO patch 
size
A representative CCO-stained section was selected for each 
sample, and this section was used for manual quantification of 
CCO activity and bifurcation events. We recorded the number 
of wild-type crypts (brown stain) and the number of crypts defi-
cient of CCO activity (blue). Crypts with a fraction of the crypt 
that was CCO-deficient were designated ‘partial crypts’.
Bifurcation events were identified as ‘8-shaped’ pairs of crypts 
that shared a portion of their border, and each event was veri-
fied as a true bifurcation event by following the crypts through 
serial sections. Each event was classified as ‘type I’ (involving 
two CCO-proficient crypts), ‘type II’ (involving two CCO-defi-
cient crypts) or ‘type III’ (involving a CCO-proficient crypt and 
a CCO-deficient crypt). Rare bifurcation events that involved 
partial CCO-deficient crypts were classed as ‘type I’ events.
Three-dimensional reconstruction of crypt bifurcation
A fresh frozen sample of colonic epithelium from patient 7 
was sectioned through at 6 µm thickness and stained for CCO 
activity as described above. Individual sections were scanned 
and registered in FreeD for 3D reconstruction, as follows. Serial 
images (TIFF file format) were imported into FreeD software 
V.1.10 image stack files. Gland boundaries were drawn manually 
in each two-dimensional (2D) serial image and connected along 
the third dimension between adjacent slides. This procedure is 
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facilitated by simultaneous display of masked gland boundaries 
during virtual microscopy in FreeD software. After manual 2D 
assessment of all virtual tissue slides of one stack, 3D models can 
be computed and visualised by interconnection of the defined 
masks along the third dimension in FreeD software.
Crypt isolation
A fresh tissue biopsy from a female aged 66 years with inac-
tive IBD was sampled immediately after endoscopic removal. 
The biopsy tissue was incubated at 37°C for 10 min in calci-
um-free and magnesium-free Dulbecco’s modified eagle medium 
(DMEM) containing 30 mmol/L EDTA. The tissue was then 
agitated in DMEM containing calcium and magnesium for 30 s 
to separate the crypts from the lamina propria mucosa and 
fibrous stroma. A bifurcating crypt was observed, photographed 
and isolated under a dissecting microscope (Olympus model 
SZ60). The two arms and the stalk were separated and used for 
methylation analysis.
Methylation analysis
Analysis of methylation patterns was performed as previously 
described.19 Briefly, DNA was extracted from the isolated crypt 
stalk and arms using the Arcturus Picopure DNA extraction 
buffer (Thermo Fisher Scientific) then bisulfite converted. A 
nested PCR was used to amplify the non-expressed CSX locus. 
PCR products were single-strand cloned, sequenced and analysed 
for methylation of the 8 CpG islands in the locus. The pattern 
of methylation revealed in each DNA strand was termed a ‘tag’.
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